ArticlePloS one2022

Selection of human single domain antibodies (sdAb) against thymidine kinase 1 and their incorporation into sdAb-Fc antibody constructs for potential use in cancer therapy.

Edwin J Velazquez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.